바이오인포매틱스 서비스 시장 : 시장 규모, 점유율, 동향 분석(유형별, 용도별, 부문별, 지역별), 부문별 예측(2025-2030년)

Bioinformatics Services Market Growth & Trends:

The global bioinformatics services market size is expected to reach USD 7.11 billion by 2030, registering a CAGR of 14.46% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing adoption of I.T. solutions for different studies such as cell signaling, pathway metabolism, gene-receptor interactions, and target differentiation are expected to support growth in this market over the forecast period.

Owing to the benefits associated with the use of informatic solutions for laboratory protocol generation and data management as well as analysis, these solutions are projected to witness substantial demand in the coming years.

Moreover, collaborative activities undertaken by the information technology companies with pharmaceutical companies and clinical research organizations in order to develop and update key technologies linked to cloud computing, like online data storage and visualization of computer resources are expected to enhance market potential through to 2024.

Bioinformatics Services Market Report Highlights:

• The NGS segment accounted for the largest market revenue share of 34.85% in 2024 and is expected to register the largest CAGR during the forecast period. The scientific software testing segment is expected to register significant CAGR during the forecast period.
• The drug discovery application segment accounted for the largest market revenue share of 24.68% in 2024. The proteomics segment is expected to witness the highest CAGR over the forecast period.
• The academic segment accounted for the largest market revenue share in 2024. The animal sector is expected to witness significant growth over the forecast period.
• North America bioinformatics services market dominated the industry in 2024 with market share of 45.70%. The Asia Pacific bioinformatics services industry is expected to witness the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. Sector
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Biohacking Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing Demand for Precision Medicine & Genomic Research
    • 3.2.1.2. Rising Investments & Government Initiatives
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Costs & Data Security Concerns
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Bioinformatics Services Market: Type Estimates & Trend Analysis

• 4.1. Type Segment Dashboard
• 4.2. Global Bioinformatics Services Market Type Movement Analysis
• 4.3. Global Bioinformatics Services Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. NGS
  • 4.4.1. NGS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Targeted Sequencing Analysis
    • 4.4.2.1. Targeted Sequencing Analysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Transcriptome Analysis
    • 4.4.3.1. Transcriptome Analysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Whole Genome
    • 4.4.4.1. Whole Genome Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.5. Chip Seq Analysis
    • 4.4.5.1. Chip Seq Analysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.6. De novo Assembly
    • 4.4.6.1. De novo Assembly Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.7. Methyl Seq Analysis
    • 4.4.7.1. Methyl Seq Analysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Chemoinformatics
  • 4.5.1. Chemoinformatics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Sequence Analysis Platforms
    • 4.5.2.1. Sequence Analysis Platforms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Molecular Modeling
    • 4.5.3.1. Molecular Modeling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Docking
    • 4.5.4.1. Docking Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.5. Clinical trial data management
    • 4.5.5.1. Clinical Trial Data Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.6. Others
    • 4.5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Microarray Data Analysis
  • 4.6.1. Microarray Data Analysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Biological Data Curation
  • 4.7.1. Biological Data Curation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Scientific Software Testing
  • 4.8.1. Scientific Software Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.9. Other Services
  • 4.9.1. Other Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Bioinformatics Services Market: Application Estimates & Trend Analysis

• 5.1. Application Segment Dashboard
• 5.2. Global Bioinformatics Services Market Application Movement Analysis
• 5.3. Global Bioinformatics Services Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Genomics
  • 5.4.1. Genomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Transcriptomics
  • 5.5.1. Transcriptomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Proteomics
  • 5.6.1. Proteomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Metabolomics
  • 5.7.1. Metabolomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Drug Discovery
  • 5.8.1. Drug Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Bioinformatics Services Market: Sector Estimates & Trend Analysis

• 6.1. Sector Segment Dashboard
• 6.2. Global Bioinformatics Services Market Sector Movement Analysis
• 6.3. Global Bioinformatics Services Market Size & Trend Analysis, by Sector, 2018 to 2030 (USD Million)
• 6.4. Medical
  • 6.4.1. Medical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Animal
  • 6.5.1. Animal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Agricultural
  • 6.6.1. Agricultural Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Academics
  • 6.7.1. Academics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Bioinformatics Services Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 7.4. North America
  • 7.4.1. North America Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. U.S. Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Canada Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. Mexico Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. UK Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Germany Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. France Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Italy Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Spain Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Denmark Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Sweden Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Norway Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Japan Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. China Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. India Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Australia Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Thailand Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. South Korea
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. South Korea Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Brazil Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Argentina Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. South Africa Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Saudi Arabia Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. UAE Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Kuwait Bioinformatics Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Categorization
• 8.2. Company Market Position Analysis, 2024
• 8.3. Participant's Overview
  • 8.3.1. Agilent Technologies, Inc.
    • 8.3.1.1. Participant's Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Product Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. BGI Group
    • 8.3.2.1. Participant's Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Product Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Dotmatics
    • 8.3.3.1. Participant's Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Product Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Labvantage - Biomax GmbH
    • 8.3.4.1. Participant's Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Product Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. CD Genomics
    • 8.3.5.1. Participant's Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Product Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Creative Biolabs
    • 8.3.6.1. Participant's Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Product Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. DNAnexus, Inc.
    • 8.3.7.1. Participant's Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Product Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. DNASTAR
    • 8.3.8.1. Participant's Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Product Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Fios Genomics
    • 8.3.9.1. Participant's Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Product Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. Illumina, Inc.
    • 8.3.10.1. Participant's Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Product Benchmarking
    • 8.3.10.4. Strategic Initiatives
  • 8.3.11. PerkinElmer Inc.
    • 8.3.11.1. Participant's Overview
    • 8.3.11.2. Financial Performance
    • 8.3.11.3. Product Benchmarking
    • 8.3.11.4. Strategic Initiatives
  • 8.3.12. QIAGEN
    • 8.3.12.1. Participant's Overview
    • 8.3.12.2. Financial Performance
    • 8.3.12.3. Product Benchmarking
    • 8.3.12.4. Strategic Initiatives
  • 8.3.13. Thermo Fisher Scientific Inc.
    • 8.3.13.1. Participant's Overview
    • 8.3.13.2. Financial Performance
    • 8.3.13.3. Product Benchmarking
    • 8.3.13.4. Strategic Initiatives